{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:10:01Z","timestamp":1767499801093,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.eprac.2023.06.001","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T22:20:05Z","timestamp":1686262805000},"page":"681-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019\u2013Related Hospital Outcomes in Patients with Type 2 Diabetes"],"prefix":"10.1016","volume":"29","author":[{"given":"Derrick","family":"Obiri-Yeboah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Alwakeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Buehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinni","family":"Makin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M.","family":"Pantalone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7364-5550","authenticated-orcid":false,"given":"M. Cecilia","family":"Lansang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.eprac.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.4158\/EP-2020-0466","article-title":"Metformin use in diabetes prior to hospitalization: effects on mortality in covid-19","volume":"26","author":"Li","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2023.06.001_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.600439","article-title":"Metformin use is associated with reduced mortality in a diverse population with COVID-19 and diabetes","volume":"11","author":"Crouse","year":"2021","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.2337\/dci20-0062","article-title":"Reduced COVID-19 mortality with sitagliptin treatment? Weighing the dissemination of potentially lifesaving findings against the assurance of high scientific standards","volume":"43","author":"Nauck","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.2337\/dc20-1340","article-title":"Impact of comorbidities and glycemia at admission and dipeptidyl peptidase 4 inhibitors in patients with type 2 diabetes with COVID-19: A case series from an academic hospital in Lombardy, Italy","volume":"43","author":"Mirani","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.eprac.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control, retrospective, observational study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.eprac.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-8587(21)00050-4","article-title":"Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England","volume":"9","author":"Khunti","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.2337\/dc21-1351","article-title":"Prior glucose-lowering medication use and 30-day outcomes among 64,892 veterans with diabetes and COVID-19","volume":"44","author":"Wander","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.eprac.2023.06.001_bib9","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.chest.2020.05.580","article-title":"Individualizing risk prediction for positive coronavirus disease 2019 testing: results from 11,672 patients","volume":"158","author":"Jehi","year":"2020","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.eprac.2023.06.001_bib10","first-page":"649","article-title":"COVID-19 and comorbidities: a role for dipeptidyl peptidase 4 (DPP4) in disease severity?","volume":"12","author":"Bassendine","year":"2020","journal-title":"J\u00a0Diabetes"},{"issue":"1","key":"10.1016\/j.eprac.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S2666-7568(20)30033-7","article-title":"Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis","volume":"2","author":"Bramante","year":"2020","journal-title":"Lancent Healthy Longev"},{"issue":"1","key":"10.1016\/j.eprac.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4269\/ajtmh.20-0375","article-title":"Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis","volume":"103","author":"Luo","year":"2020","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.eprac.2023.06.001_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3476","article-title":"Elevated HbA1c levels in pre-Covid-19 infection increases the risk of mortality: a systematic review and meta-analysis","volume":"38","author":"Prattichizzo","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.eprac.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.arcmed.2021.08.002","article-title":"Association between anti-diabetic agents and clinical outcomes of COVID-19 in patients with diabetes: a systematic review and meta-analysis","volume":"53","author":"Han","year":"2022","journal-title":"Arch Med Res"},{"issue":"3","key":"10.1016\/j.eprac.2023.06.001_bib15","first-page":"207","article-title":"Does DPP-4 inhibitor treatment affect the clinical outcomes of COVID-19 in type 2 diabetes mellitus patients?","volume":"9","author":"Erol","year":"2022","journal-title":"North Clin Istanb"},{"key":"10.1016\/j.eprac.2023.06.001_bib16","article-title":"The association between antidiabetic agents and clinical outcomes of COVID-19 patients with diabetes: a Bayesian network meta-analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.eprac.2023.06.001_bib17","first-page":"308","article-title":"Health outcomes and economic burden of hospitalized COVID-19 patients in the United States","volume":"24","author":"Di Fusco","year":"2021","journal-title":"J\u00a0Med Econ"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23004299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23004299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:42Z","timestamp":1761516882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23004299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1530891X23004299"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.06.001","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Metformin, Dipeptidyl Dipeptidase-4 Inhibitors, and Insulin with Coronavirus Disease 2019\u2013Related Hospital Outcomes in Patients with Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}